Form 4: OnKure Therapeutics CFO Receives Stock Grant
Insider Transaction (Form 4)
Jason A. Leverone, Chief Financial Officer of OnKure Therapeutics, Inc., reported multiple transactions in common stock on August 7, 2026.
Summary
- Grant/award: acquired 50,000 Employee Stock Option (right to buy) on August 7, 2026; holds 50,000 after (Direct).
- Disposition to the issuer: disposed of 5,781 Employee Stock Option (right to buy on August 7, 2026 (Direct).
- Grant/award: acquired 5,781 Employee Stock Option (right to buy on August 7, 2026; holds 5,781 after (Direct).
- Disposition to the issuer: disposed of 5,322 Employee Stock Option (right to buy) on August 7, 2026 (Direct).
- Grant/award: acquired 5,322 Employee Stock Option (right to buy) on August 7, 2026; holds 5,322 after (Direct).
- Disposition to the issuer: disposed of 130,611 Employee Stock Option (right to buy) on August 7, 2026 (Direct).
- Grant/award: acquired 130,611 Employee Stock Option (right to buy) on August 7, 2026; holds 130,611 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Jason A. Leverone — Officer (Chief Financial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-07 | Grant/award | Employee Stock Option (right to buy) | 50,000 | — | — | 50,000 |
| 2026-08-07 | Disposition to the issuer | Employee Stock Option (right to buy | 5,781 | — | — | 0 |
| 2026-08-07 | Grant/award | Employee Stock Option (right to buy | 5,781 | — | — | 5,781 |
| 2026-08-07 | Disposition to the issuer | Employee Stock Option (right to buy) | 5,322 | — | — | 0 |
| 2026-08-07 | Grant/award | Employee Stock Option (right to buy) | 5,322 | — | — | 5,322 |
| 2026-08-07 | Disposition to the issuer | Employee Stock Option (right to buy) | 130,611 | — | — | 0 |
| 2026-08-07 | Grant/award | Employee Stock Option (right to buy) | 130,611 | — | — | 130,611 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-07 | Grant/award (50,000 shares) |
| 2026-08-07 | Disposition to the issuer (5,781 shares) |
| 2026-08-07 | Grant/award (5,781 shares) |
| 2026-08-07 | Disposition to the issuer (5,322 shares) |
| 2026-08-07 | Grant/award (5,322 shares) |
| 2026-08-07 | Disposition to the issuer (130,611 shares) |
| 2026-08-07 | Grant/award (130,611 shares) |
Keywords
insider transaction, Form 4, OKUR, OnKure Therapeutics, Inc., neutral, Jason A. Leverone
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.